Header Logo

Connection

Michelle Callegan to Staphylococcal Infections

Back to Details
This is a "connection" page, showing publications Michelle Callegan has written about Staphylococcal Infections.
Michelle Callegan
Connection Strength
3.001
Staphylococcal Infections
  1. The Role of CCL Chemokines in Experimental Staphylococcus aureus Endophthalmitis. Invest Ophthalmol Vis Sci. 2024 Jun 03; 65(6):12.
    View in: PubMed
    Score: 0.869
  2. The Role of C-X-C Chemokines in Staphylococcus aureus Endophthalmitis. Invest Ophthalmol Vis Sci. 2023 Mar 01; 64(3):10.
    View in: PubMed
    Score: 0.797
  3. Blood-Retinal Barrier Compromise and Endogenous Staphylococcus aureus Endophthalmitis. Invest Ophthalmol Vis Sci. 2015 Nov; 56(12):7303-11.
    View in: PubMed
    Score: 0.479
  4. Disarming Pore-Forming Toxins with Biomimetic Nanosponges in Intraocular Infections. mSphere. 2019 05 15; 4(3).
    View in: PubMed
    Score: 0.153
  5. Efficacy of tobramycin drops applied to collagen shields for experimental staphylococcal keratitis. Curr Eye Res. 1994 Dec; 13(12):875-8.
    View in: PubMed
    Score: 0.112
  6. Ciprofloxacin versus tobramycin for the treatment of staphylococcal keratitis. Invest Ophthalmol Vis Sci. 1994 Mar; 35(3):1033-7.
    View in: PubMed
    Score: 0.107
  7. Methicillin-resistant Staphylococcus aureus keratitis in the rabbit: therapy with ciprofloxacin, vancomycin and cefazolin. Curr Eye Res. 1992 Nov; 11(11):1111-9.
    View in: PubMed
    Score: 0.097
  8. Topical antibiotic therapy for the treatment of experimental Staphylococcus aureus keratitis. Invest Ophthalmol Vis Sci. 1992 Oct; 33(11):3017-23.
    View in: PubMed
    Score: 0.097
  9. Checks and balances: the ocular response to infection. Virulence. 2010 Jul-Aug; 1(4):222.
    View in: PubMed
    Score: 0.083
  10. Corneal expression of the inflammatory mediator CAP37. Invest Ophthalmol Vis Sci. 2002 May; 43(5):1414-21.
    View in: PubMed
    Score: 0.047
  11. Molecular epidemiology of Staphylococcus aureus and Enterococcus faecalis in endophthalmitis. Infect Immun. 1998 Jan; 66(1):356-60.
    View in: PubMed
    Score: 0.035
  12. Specific roles of alpha-toxin and beta-toxin during Staphylococcus aureus corneal infection. Infect Immun. 1997 May; 65(5):1571-8.
    View in: PubMed
    Score: 0.033
  13. Staphylococcal accessory regulator (sar) in conjunction with agr contributes to Staphylococcus aureus virulence in endophthalmitis. Infect Immun. 1997 Apr; 65(4):1550-6.
    View in: PubMed
    Score: 0.033
  14. The effectiveness of two ciprofloxacin formulations for experimental Pseudomonas and Staphylococcus keratitis. Jpn J Ophthalmol. 1996; 40(2):212-9.
    View in: PubMed
    Score: 0.030
  15. Pharmacokinetic considerations in the treatment of bacterial keratitis. Clin Pharmacokinet. 1994 Aug; 27(2):129-49.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.